Compare Novartis AG (NVS) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Schlumberger NV — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Schlumberger NV trades at $46.39 (market cap $69.36B). The key difference: Novartis AG is far larger — about 4.2× Schlumberger NV's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | SLB | |
|---|---|---|
Market Cap | $290.25B | $69.36B |
Sector | Health | Energy |
52-Week High | $168.62 | $58.01 |
52-Week Low | $113.50 | $31.72 |
Enterprise Value | $330.27B | $77.58B |
Dividend Yield | 3.17% | 2.54% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
